David Erlinge
201 – 210 of 473
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Design and rationale for the Influenza vaccination After Myocardial Infarction (IAMI) trial. A registry-based randomized clinical trial
(
- Contribution to journal › Article
-
Mark
Unfractionated heparin versus bivalirudin in patients undergoing primary percutaneous coronary intervention : A SWEDEHEART study
(
- Contribution to journal › Article
-
Mark
Infectious complications after out-of-hospital cardiac arrest—A comparison between two target temperatures
(
- Contribution to journal › Article
-
Mark
Medical Therapy for Secondary Prevention and Long-Term Outcome in Patients with Myocardial Infarction with Non-Obstructive Coronary Artery (MINOCA) Disease
(
- Contribution to journal › Article
-
Mark
Instantaneous wave-free ratio versus fractional flow reserve to guide PCI
(
- Contribution to journal › Article
-
Mark
Intravascular Ultrasound Guidance is Associated with Better Outcome in Patients Undergoing Unprotected Left Main Coronary Artery Stenting Compared with Angiography Guidance Alone
(
- Contribution to journal › Article
-
Mark
Proteomics in Hypothermia as Adjunctive Therapy in Patients with ST-Segment Elevation Myocardial Infarction : A CHILL-MI Substudy
(
- Contribution to journal › Article
-
Mark
P2Y2 receptor modulates shear stress-induced cell alignment and actin stress fibers in human umbilical vein endothelial cells
(
- Contribution to journal › Article
-
Mark
Cangrelor in combination with ticagrelor provides consistent and potent P2Y12-inhibition during and after primary percutaneous coronary intervention in real-world patients with ST-segment-elevation myocardial infarction
(
- Contribution to journal › Article
-
Mark
The Rationale for and Clinical Pharmacology of Prasugrel 5 mg
(
- Contribution to journal › Article